Formerly known as Kumpulan Powernet Bhd, the group operates in the sustainable energy and utilities segment and specialises in renewable energy (RE).
PETALING JAYA: KPower Bhd has inked a US$6mil (RM24.05mil) contract to supply polymerase chain reaction (PCR) reagent kits for Covid-19 to PT Arna Cahaya Medika in Jakarta, Indonesia.
Under the deal, the group’s wholly-owned subsidiary KPower Healthcare and Technologies Sdn Bhd will request for the supply of the PCR Kits from the relevant appointed manufacturer, before delivering them to Jakarta.
, the group operates in the sustainable energy and utilities segment and specialises in renewable energy (RE).
KUALA LUMPUR: Shares in KPower, which has been on an uptrend, climbed to a record high in early trade Wednesday as investors reacted positively on its venture into the medical sector.
The counter added 3.5%, or 27 sen to RM7.99. It is currently trading at a PE ratio of 45.6 times.
KPower has entered into a share sale agreement to acquire a 70% stake in Granulab (M) Sdn Bhd, a wholly owned unit of SIRIM Bhd’s subsidiary, Sirim Tech Venture Sdn Bhd, for RM1mil cash.
Granulab is involved in medical device manufacturing for granular synthetic bone graft “Granumas”, the only halal synthetic bone graft product in Malaysia, and producing medical devices and products.